Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts. It was founded in 2010 and went public on Nasdaq in 2018. The name combines the words modified and RNA. The company reports results in dollars. It employs thousands of staff across its offices and sites in the United States, and it also supplies vaccines to countries through government contracts.

The company develops medicines and vaccines based on messenger RNA. Its Spikevax vaccine against covid-19 received authorization in late 2020. Moderna has also gained approval for a respiratory syncytial virus vaccine and has cancer and rare disease programs in trials.

Moderna works with partners and government bodies on vaccine supply. It operates a manufacturing site in Norwood, Massachusetts. The company is led by Stephane Bancel. The company has also tested treatments for flu, cytomegalovirus and cancer. Revenue fell sharply after the covid-19 vaccine demand dropped. Competitors include Pfizer and BioNTech.